Abacus Planning Group, Inc. Johnson & Johnson Transaction History

Abacus Planning Group, Inc.

$552 Million
Q1 2025

A detailed history of Abacus Planning Group, Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Abacus Planning Group, Inc. holds 10,030 shares of JNJ stock, worth $1.55 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares

10,030

Previous 9,544 5.09%

Holding current value

$1.55 Million

Previous $1.38 Million 20.51%

% of portfolio

0.3%

Previous 0.25%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 14, 2025	BUY	$142.06 - $167.7 $69,041 - $81,502	486 Added 5.09%	10,030 $1.66 Million
Q4 2024 Jan 31, 2025	SELL	$143.34 - $165.86 $148,500 - $171,830	-1,036 Reduced 9.79%	9,544 $1.38 Million
Q3 2024 Oct 02, 2024	BUY	$145.48 - $167.38 $228,549 - $262,953	1,571 Added 17.44%	10,580 $1.71 Million
Q2 2024 Jul 30, 2024	BUY	$144.38 - $157.78 $120,846 - $132,061	837 Added 10.24%	9,009 $1.32 Million
Q1 2024 Apr 11, 2024	SELL	$155.22 - $162.74 $83,508 - $87,554	-538 Reduced 6.18%	8,172 $1.29 Million
Q4 2023 Jan 19, 2024	SELL	$145.6 - $158.88 $25,916 - $28,280	-178 Reduced 2.0%	8,710 $1.37 Million
Q3 2023 Oct 11, 2023	SELL	$155.75 - $174.48 $10,123 - $11,341	-65 Reduced 0.73%	8,888 $1.38 Million
Q2 2023 Jul 06, 2023	BUY	$154.35 - $166.11 $31,333 - $33,720	203 Added 2.32%	8,953 $1.48 Million
Q1 2023 Apr 17, 2023	BUY	$151.05 - $180.26 $453 - $540	3 Added 0.03%	8,750 $1.36 Million
Q4 2022 Jan 19, 2023	BUY	$160.2 - $179.79 $320 - $359	2 Added 0.02%	8,747 $0
Q3 2022 Oct 18, 2022	SELL	$161.33 - $179.52 $57,272 - $63,729	-355 Reduced 3.9%	8,745 $1.43 Million
Q2 2022 Jul 18, 2022	SELL	$168.19 - $186.01 $109,828 - $121,464	-653 Reduced 6.7%	9,100 $1.62 Million
Q4 2021 Jan 18, 2022	BUY	$155.93 - $173.01 $55,199 - $61,245	354 Added 3.77%	9,753 $1.67 Million
Q3 2021 Oct 19, 2021	BUY	$161.5 - $179.47 $161 - $179	1 Added 0.01%	9,399 $1.52 Million
Q2 2021 Jul 20, 2021	SELL	$159.48 - $171.07 $239,060 - $256,433	-1,499 Reduced 13.76%	9,398 $1.55 Million
Q1 2021 Apr 27, 2021	SELL	$153.07 - $170.48 $4,439 - $4,943	-29 Reduced 0.27%	10,897 $1.79 Million
Q4 2020 Feb 01, 2021	SELL	$137.11 - $157.38 $37,293 - $42,807	-272 Reduced 2.43%	10,926 $1.72 Million
Q3 2020 Nov 03, 2020	BUY	$140.38 - $153.83 $55,871 - $61,224	398 Added 3.69%	11,198 $1.67 Million
Q2 2020 Aug 11, 2020	SELL	$128.81 - $155.51 $26,277 - $31,724	-204 Reduced 1.85%	10,800 $1.52 Million
Q1 2020 Apr 30, 2020	SELL	$111.14 - $153.99 $22,228 - $30,798	-200 Reduced 1.79%	11,004 $1.44 Million
Q4 2019 Jan 30, 2020	BUY	$127.5 - $146.44 $43,860 - $50,375	344 Added 3.17%	11,204 $1.63 Million
Q3 2019 Nov 01, 2019	BUY	$126.95 - $142.14 $247,933 - $277,599	1,953 Added 21.93%	10,860 $1.41 Million
Q2 2019 Aug 12, 2019	SELL	$131.15 - $144.24 $66,099 - $72,696	-504 Reduced 5.36%	8,907 $1.24 Million
Q1 2019 Apr 25, 2019	BUY	$125.72 - $139.79 $125 - $139	1 Added 0.01%	9,411 $1.32 Million
Q4 2018 Feb 15, 2019	SELL	$122.84 - $147.84 $578,330 - $696,030	-4,708 Reduced 33.35%	9,410 $1.21 Million
Q4 2018 Feb 14, 2019	BUY	$122.84 - $147.84 $578,330 - $696,030	4,708 Added 50.03%	14,118 $553,000
Q4 2018 Jan 25, 2019	SELL	$122.84 - $147.84 $82,425 - $99,200	-671 Reduced 6.66%	9,410 $1.21 Million
Q3 2018 Oct 31, 2018	BUY	$121.58 - $142.88 $48,875 - $57,437	402 Added 4.15%	10,081 $1.39 Million
Q2 2018 Jul 27, 2018	BUY	$119.4 - $131.76 $91,102 - $100,532	763 Added 8.56%	9,679 $1.17 Million
Q1 2018 May 04, 2018	BUY	$125.1 - $148.14 $149,494 - $177,027	1,195 Added 15.48%	8,916 $1.14 Million
Q4 2017 Mar 06, 2018	BUY	$131.22 - $143.62 $1.01 Million - $1.11 Million	7,721	7,721 $1.08 Million

Others Institutions Holding JNJ

# of Institutions

4,604

Shares Held

1.71B

Call Options Held

16.9M

Put Options Held

14.1M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $405B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Abacus Planning Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Abacus Planning Group, Inc. with notifications on news.

Account

Abacus Planning Group, Inc. Johnson & Johnson Transaction History